Pharmacokinetics of metformin during pregnancy

Drug Metabolism and Disposition

Volumn 38, Issue 5, 2010, Pages 833-840

  Eyal, Sara ^a   Easterling, Thomas R ^b   Carr, Darcy ^b   Umans, Jason G ^c   Miodovnik, Menachem ^c   Hankins, Gary D V ^d   Clark, Shannon M ^d   Risler, Linda ^a   Wang, Joanne ^a   Kelly, Edward J ^a   Shen, Danny D ^a   Hebert, Mary F ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; METFORMIN;

ARTICLE; BLOOD SAMPLING; BODY WEIGHT; BREAST MILK; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; DELIVERY; DRUG ELIMINATION; FEMALE; FIRST TRIMESTER PREGNANCY; GLOMERULUS FILTRATION; HUMAN; KIDNEY CLEARANCE; KIDNEY TUBULE ABSORPTION; MATERNAL BLOOD; PRENATAL EXPOSURE; PRIORITY JOURNAL; PUERPERIUM; STEADY STATE; THIRD TRIMESTER PREGNANCY; UMBILICAL CORD BLOOD; URINALYSIS;

ADULT; AREA UNDER CURVE; CREATININE; FEMALE; FETAL BLOOD; GENOTYPE; HUMANS; INFANT, NEWBORN; KIDNEY; METABOLIC CLEARANCE RATE; METFORMIN; MILK, HUMAN; ORGANIC CATION TRANSPORT PROTEINS; POSTPARTUM PERIOD; PREGNANCY; PREGNANCY TRIMESTERS;

EID: 77950950434     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.109.031245     Document Type: Article

References (38)

1. Alnouti Y, Petrick JS, and Klaassen CD (2006) Tissue distribution and ontogeny of organic cation transporters in mice. Drug Metab Dispos 34:477-482. (Pubitemid 43290907)
2. American Academy of Pediatrics Work Group on Breastfeeding (1997) Breastfeeding and the use of human milk. Pediatrics 100:1035-1039.
3. Andrew MA, Easterling TR, Carr DB, Shen D, Buchanan ML, Rutherford T, Bennett R, Vicini P, and Hebert MF (2007) Amoxicillin pharmacokinetics in pregnant women: modeling and simulations of dosage strategies. Clin Pharmacol Ther 81:547-556.
4. Becker ML, Visser LE, van Schaik RH, Hofman A, Uitterlinden AG, and Stricker BH (2009) Genetic variation in the multidrug and toxin extrusion 1 transporter protein influences the glucose-lowering effect of metformin in patients with diabetes: a preliminary study. Diabetes 58:745-749.
5. Briggs GG, Ambrose PJ, Nageotte MP, Padilla G, and Wan S (2005) Excretion of metformin into breast milk and the effect on nursing infants. Obstet Gynecol 105:1437-1441.
6. Charles B, Norris R, Xiao X, and Hague W (2006) Population pharmacokinetics of metformin in late pregnancy. Ther Drug Monit 28:67-72.
7. Chen Y, Li S, Brown C, Cheatham S, Castro RA, Leabman MK, Urban TJ, Chen L, Yee SW, Choi JH, et al. (2009) Effect of genetic variation in the organic cation transporter 2 on the renal elimination of metformin. Pharmacogenet Genomics 19:497-504.
8. Davison JM and Dunlop W (1980) Renal hemodynamics and tubular function normal human pregnancy. Kidney Int 18:152-161.
9. Gardiner SJ, Kirkpatrick CM, Begg EJ, Zhang M, Moore MP, and Saville DJ (2003) Transfer of metformin into human milk. Clin Pharmacol Ther 73:71-77.
10. Gardiner SJ, Kirkpatrick CM, Zhang M, and Begg EJ (2008) Cimetidine does not appear to influence the distribution of metformin into human milk. Br J Clin Pharmacol 66:564-565.
11. Glueck CJ, Goldenberg N, Pranikoff J, Loftspring M, Sieve L, and Wang P (2004) Height, weight, and motor-social development during the first 18 months of life in 126 infants born to 109 mothers with polycystic ovary syndrome who conceived on and continued metformin through pregnancy. Hum Reprod 19:1323-1330.
12. Guideline Development Group (2008) Management of diabetes from preconception to the postnatal period: summary of NICE guidance. BMJ 336:714-717.
13. Hague WM, Davoren PM, McIntyre D, Norris R, Xiaonian X, and Charles B (2003) Metformin crosses the placenta: a modular for fetal insulin resistance (Letter)? Br Med J 327:880-881.
14. Hale TW, Kristensen JH, Hackett LP, Kohan R, and Ilett KF (2002) Transfer of metformin into human milk. Diabetologia 45:1509-1514.
15. Hebert MF, Carr DB, Anderson GD, Blough D, Green GE, Brateng DA, Kantor E, Benedetti TJ, and Easterling TR (2005) Pharmacokinetics and pharmacodynamics of atenolol during pregnancy and postpartum. J Clin Pharmacol 45:25-33.
16. Hebert MF, Easterling TR, Kirby B, Carr DB, Buchanan ML, Rutherford T, Thummel KE, Fishbein DP, and Unadkat JD (2008) Effects of pregnancy on CYP3A and P-glycoprotein activities as measured by disposition of midazolam and digoxin: a University of Washington specialized center of research study. Clin Pharmacol Ther 84:248-253.
17. Hebert MF, Ma X, Naraharisetti SB, Krudys KM, Umans JG, Hankins GD, Caritis SN, Miodovnik M, Mattison DR, Unadkat JD, Kelly EJ, Blough D, Cobelli C, Ahmed MS, Snodgrass WR, Carr DB, Easterling TR, Vicini P, and Obstetric-Fetal Pharmacology Research Unit Network. (2009) Are we optimizing gestational diabetes treatment with glyburide? The pharmacologic basis for better clinical practice. Clin Pharmacol Ther 85:607-614.
18. Hughes RC, Gardiner SJ, Begg EJ, and Zhang M (2006) Effect of pregnancy on the pharmacokinetics of metformin. Diabet Med 23:323-326.
19. Kimura N, Okuda M, and Inui K (2005) Metformin transport by renal basolateral organic cation transporter hOCT2. Pharm Res 22:255-259.
20. Krentz AJ and Bailey CJ (2005) Oral antidiabetic agents: current role in type 2 diabetes mellitus. Drugs 65:385-411.
21. Lord JM, Flight IH, and Norman RJ (2003) Metformin in polycystic ovary syndrome: systematic review and meta-analysis. BMJ 327:951-953.
22. Pentikäinen PJ, Neuvonen PJ, and Penttilä A (1979) Pharmacokinetics of metformin after intravenous and oral administration to man. Eur J Clin Pharmacol 16:195-202.
23. Rowan JA, Hague WM, Gao W, Battin MR, Moore MP, and MiG Trial Investigators (2008) Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med 358:2003-2015.
24. Sambol NC, Chiang J, Lin ET, Goodman AM, Liu CY, Benet LZ, and Cogan MG (1995) Kidney function and age are both predictors of pharmacokinetics of metformin. J Clin Pharmacol 35:1094-1102.
25. Scheen AJ (1996) Clinical pharmacokinetics of metformin. Clin Pharmacokinet 30:359-371.
26. Shu Y, Bello CL, Mangravite LM, Feng B, and Giacomini KM (2001) Functional characteristics and steroid hormone-mediated regulation of an organic cation transporter in Madin-Darby canine kidney cells. J Pharmacol Exp Ther 299:392-398.
27. Shu Y, Brown C, Castro RA, Shi RJ, Lin ET, Owen RP, Sheardown SA, Yue L, Burchard EG, Brett CM, et al. (2008) Effect of genetic variation in the organic cation transporter 1, OCT1, on metformin pharmacokinetics. Clin Pharmacol Ther 83:273-280.
28. Song IS, Shin HJ, Shim EJ, Jung IS, Kim WY, Shon JH, and Shin JG (2008) Genetic variants of the organic cation transporter 2 influence the disposition of metformin. Clin Pharmacol Ther 84:559-562.
29. Sturgiss SN, Dunlop W, and Davison JM (1994) Renal haemodynamics and tubular function in human pregnancy. Baillieres Clin Obstet Gynaecol 8:209-234.
30. Tanihara Y, Masuda S, Sato T, Katsura T, Ogawa O, and Inui K (2007) Substrate specificity of MATE1 and MATE2-K, human multidrug and toxin extrusions/H(+)-organic cation antiporters. Biochem Pharmacol 74:359-371.
31. Tucker GT, Casey C, Phillips PJ, Connor H, Ward JD, and Woods HF (1981) Metformin kinetics in healthy subjects and in patients with diabetes mellitus. Br J Clin Pharmacol 12:235-246.
32. Tzvetkov MV, Vormfelde SV, Balen D, Meineke I, Schmidt T, Sehrt D, Sabolić I, Koepsell H, and Brockmöller J (2009) The effects of genetic polymorphisms in the organic cation transporters OCT1, OCT2, and OCT3 on the renal clearance of metformin. Clin Pharmacol Ther 86:299-306.
33. Urakami Y, Nakamura N, Takahashi K, Okuda M, Saito H, Hashimoto Y, and Inui K (1999) Gender differences in expression of organic cation transporter OCT2 in rat kidney. FEBS Lett 461:339-342. (Pubitemid 29533359)
34. Vanky E, Zahlsen K, Spigset O, and Carlsen SM (2005) Placental passage of metformin in women with polycystic ovary syndrome. Fertil Steril 83:1575-1578. (Pubitemid 40615847)
35. Wang DS, Jonker JW, Kato Y, Kusuhara H, Schinkel AH, and Sugiyama Y (2002) Involvement of organic cation transporter 1 in hepatic and intestinal distribution of metformin. J Pharmacol Exp Ther 302:510-515. (Pubitemid 34787213)
36. Wang ZJ, Yin OQ, Tomlinson B, and Chow MS (2008) OCT2 polymorphisms and in-vivo renal functional consequence: studies with metformin and cimetidine. Pharmacogenet Genomics 18:637-645.
37. Wensel TM (2009) Role of metformin in the treatment of gestational diabetes. Ann Pharmacother 43:939-943.
38. Zhou M, Xia L, and Wang J (2007) Metformin transport by a newly cloned proton-stimulated organic cation transporter (plasma membrane monoamine transporter) expressed in human intestine. Drug Metab Dispos 35:1956-1962. (Pubitemid 47481592)